Pre-hospital Morphine Titration : Comparison of 0,05 Versus 0,1 mg/kg

NCT ID: NCT00237731

Last Updated: 2017-05-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

106 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-09-30

Study Completion Date

2006-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Efficacy and safety of morphine titration on acute pain in emergency medical mobile units with initial bolus of 0.1 mg/kg plus 0.05 mg/kg versus morphine titration with initial bolus of 0.05 mg/kg plus 0.025 mg/kg

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

STUDY OBJECTIVE : Assess the efficacy of a morphine dose of 0.1 mg/kg versus a morphine dose of 0.05 mg/kg in pre-hospital pain METHODS : Consecutive patients with severe, acute pain defined as a verbal rating scale (VRS) of 60/100 or higher may be included. 106 patients at all are required in the study. They will be randomised in two groups : group A will receive an initial intravenous injection of 0.05 mg/kg then injections of 0.025 mg/kg every 5 minutes and group B will receive an initial intravenous injection 0.1 mg/kg then injections of 0.05 mg/kg every 5 minutes. The pain scale will be checked every 5 minutes during 30 minutes. The titration will be stopped before, if the VRS is \< or = 30. The patient will be followed during the study until 60 minutes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Severe, Acute Pain in a Pre-hospital Setting

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

morphine 0.05

Group Type EXPERIMENTAL

morphine

Intervention Type DRUG

morphine 0.05

2

morphine 0.10

Group Type ACTIVE_COMPARATOR

morphine

Intervention Type DRUG

morphine 0.10

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

morphine

morphine 0.05

Intervention Type DRUG

morphine

morphine 0.10

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Severe, acute pain defined by a VRS of 60/100 or higher
* Male or female over 18 years
* Cared by a medical emergency care unit
* Written informed consent
* Affiliated to social security

Exclusion Criteria

* A known opioid or paracetamol hypersensitivity
* Patient not agree ta participate at the study
* Pregnancy
* Uncontrolled epilepsia
* Incapacity to understand the VRS
* Renal, respiratory, or liver disease
* Patients who have received sedative drugs or alcohol (\< 6h)
* Acute respiratory, haemodynamic or neurologic failure
* Patients who have already received an analgesic (\< 6h)
* Drug addiction
* Patients under protection of justice
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Toulouse

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

UHToulouse

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean-Louis DUCASSE

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Toulouse, France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

SAMU 31 Hôpital PURPAN

Toulouse, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Ricard-Hibon A, Leroy N, Magne M, Leberre A, Chollet C, Marty J. [Evaluation of acute pain in prehospital medicine]. Ann Fr Anesth Reanim. 1997;16(8):945-9. doi: 10.1016/s0750-7658(97)82142-9. French.

Reference Type BACKGROUND
PMID: 9750642 (View on PubMed)

Ricard-Hibon A, Marty J. Prise en charge de la douleur en milieu préhospitalier, In SFAR, Conférences d'actualisation 2001, Paris, Elsevier,2001;pp 709-22

Reference Type BACKGROUND

SFAR. Quelles sont les modalités de réalisation d'une sédation et/ou d'une analgésie du malade en ventilation spontanée. In : SFAR eds. Modalités de la sédation et/ou de l'analgésie en situation extrahospitalière : Conférence d'experts. Paris, Elsevier;2000;pp 37-51

Reference Type BACKGROUND

SFUM. Troisième conférence de consensus en médecine d'urgence de la Société francophone d'urgence médicale. Le traitement médicamenteux de la douleur de l'adulte dans un service d'accueil et d'urgence. Réan Urg 1993; 2:321-7

Reference Type BACKGROUND

Bounes V, Charpentier S, Houze-Cerfon CH, Bellard C, Ducasse JL. Is there an ideal morphine dose for prehospital treatment of severe acute pain? A randomized, double-blind comparison of 2 doses. Am J Emerg Med. 2008 Feb;26(2):148-54. doi: 10.1016/j.ajem.2007.04.020.

Reference Type RESULT
PMID: 18272093 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.orumip.fr

Observatoire Régional Urgences Midi-Pyrénées, Rapport annuel sur l'activité des services d'urgence 2004

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

0505103

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.